G-BA source · retrieved 2026-08-05
Structured conclusion
1 source-verified result
Patient group a
Erwachsene mit mindestens 4 Migränetagen pro Monat, für die eine konventionelle Migräneprophylaxe infrage kommt
Hint of considerable added benefit
Comparator
- Metoprolol oder Propranolol oder Flunarizin oder Topiramat oder Amitriptylin oder Clostridium botulinum Toxin Typ A
Decision orientation
4 cited claims
Each claim links to the official G-BA page or an exact PDF page range.
Official metadata
Case context
Listed normative targets
A listed target is not treated as a new directive version unless an official version source exists.
Official document package